Evidence map›Paper›PMID 35415290›Full record

ReviewBioactive materials2022

Microbial resistance to nanotechnologies: An important but understudied consideration using antimicrobial nanotechnologies in orthopaedic implants.

Zhuoran Wu, Brian Chan, Jessalyn Low, Justin Jang Hann Chu, Hwee Weng Dennis Hey, Andy Tay

Abstract readReview
In one paragraph

Review in Bioactive materials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Mussel-InspiredACS omega · 2025
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Diamond-like carbon (DLC) surface treatment decreases biofilm burden by S. aureus on titanium alloy in vitro- a pilot study.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2024
    Article
  13. Observational
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhuoran WuInstitute of Health Innovation & Technology, National University of Singapore, 117599, Singapore.
Brian ChanDepartment of Biomedical Engineering, National University of Singapore, 117583, Singapore.
Jessalyn LowDepartment of Biomedical Engineering, National University of Singapore, 117583, Singapore.
Justin Jang Hann ChuBiosafety Level 3 Core Facility, Yong Loo Lin School of Medicine, National University of Singapore, 117599, Singapore.
Hwee Weng Dennis HeyNational University Health System, National University of Singapore, 119228, Singapore.
Andy TayInstitute of Health Innovation & Technology, National University of Singapore, 117599, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbial resistance to current antibiotics therapies is a major cause of implant failure and adverse clinical outcomes in orthopaedic surgery. Recent developments in advanced antimicrobial nanotechnologies provide numerous opportunities to effective remove resistant bacteria and prevent resistance from occurring through unique mechanisms. With tunable physicochemical properties, nanomaterials can be designed to be bactericidal, antifouling, immunomodulating, and capable of delivering antibacterial compounds to the infection region with spatiotemporal accuracy. Despite its substantial advancement, an important, but under-explored area, is potential microbial resistance to nanomaterials and how this can impact the clinical use of antimicrobial nanotechnologies. This review aims to provide a better understanding of nanomaterial-associated microbial resistance to accelerate bench-to-bedside translations of emerging nanotechnologies for effective control of implant associated infections.

Indexed as

Antimicrobial nanotechnologyBacterial infectionMicrobial resistanceNanomaterialOrthopaedic implant

Identifiers

PMID35415290
PMCPMC8965851

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.